Aduhelm
Biological Neurology
NDC 64406-102-02
General payments
$164,549
Research payments
$46,262,809
Through program year 2025, $164,549 in general payments and $46,262,809 in research payments were reported against Aduhelm (Neurology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $1,250 | 2 |
| 2025 | Research | $1,594,529 | 83 |
| 2024 | General | $73,051 | 106 |
| 2024 | Research | $13,519,967 | 213 |
| 2023 | General | $90,248 | 194 |
| 2023 | Research | $31,148,314 | 197 |
Breakdown
Each share is of general payments naming this product in 2025.
Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2025 where a state was reported.
Records
302 general · 493 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.